Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06904391 · ClinicalTrials.gov registry record · NA
Education & Mentorship of Advanced Practice Providers to Increase Community-based Research Within the NCORP Network, COACH-APP Trial
A NA study of Other, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 97
- Enrollment target
- 20
- Study locations
NCT06904391: Recruiting NA study of Other, sponsored by Wake Forest University Health Sciences.
NCT06904391 is a NA study of Other that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 97 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 20 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06904391, a NA study of Other, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 97 participants
- Enrollment target
- 20
- Study locations
Study Summary
This clinical trial evaluates whether a mentorship and education intervention called COACH-APP works to improve advanced practice providers' (APPs) confidence in their ability to participate in clinical research (research self-efficacy). APPs are skilled clinicians who are routinely part of cancer care teams, but who may not routinely be part of the research care team at community oncology sites. The COACH-APP program provides focused education and structured mentorship to assist in meaningful integration to the research care team, which may increase research self-efficacy among APPs and ultimately improve patient care and access to clinical trials.
Primary Outcome
RSE score is calculated as sum of the 22-items measured on a 5-point Likert scale. Will be compared between the COACH-APP intervention and education control arms using a two-sample t-test.
Conditions Studied
Interventions
- OTHER Survey Administration
- OTHER Educational Intervention
- OTHER Interview
- OTHER Behavioral Intervention
Study Locations (20)
Illinois
- Illinois Cancer Care-Bloomington - Bloomington
- Illinois Cancer Care - Eureka - Eureka
- Illinois CancerCare-Galesburg - Galesburg
- Illinois CancerCare-Macomb - Macomb
- SSM Health Good Samaritan - Mount Vernon
- Illinois Cancer Care-Pekin - Pekin
- Illinois CancerCare-Peoria - Peoria
- Illinois Cancer Care - Washington - Washington
Maine
- Harold Alfond Center for Cancer Care - Augusta
- MaineHealth Maine Medical Center - Portland - Portland
- MaineHealth Maine Medical Center- Scarborough - Scarborough
- Maine Health Cancer Care and IV Therapy - South Portland - South Portland
Hawaii
- Queen's Medical Center - Honolulu
- University of Hawaii Cancer Center - Honolulu
- The Queen's Medical Center - West Oahu - ‘Ewa Beach
Michigan
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital - Chelsea
- Corewell Health Reed City Hospital - Reed City
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus - Ypsilanti
Delaware
- Helen F Graham Cancer Center - Newark
Minnesota
- Sanford Joe Lueken Cancer Center - Bemidji
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2025-09-05 |
| Est. Completion | 2028-06-30 |
| Phase | NA |
What NCT06904391 shows while recruiting
NCT06904391 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 97 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Other appearing as the primary indexed condition, and to 4 interventions - of which Survey Administration is the first listed.
NCT06904391 names 20 study sites across 6 states, led by Illinois, Maine, Hawaii.
Frequently Asked Questions
What is clinical trial NCT06904391 about?
NCT06904391 is a clinical study titled "Education & Mentorship of Advanced Practice Providers to Increase Community-based Research Within the NCORP Network, COACH-APP Trial". This clinical trial evaluates whether a mentorship and education intervention called COACH-APP works to improve advanced practice providers' (APPs) confidence in their ability to participate in clinical research (research self-efficacy). APPs are skilled clinicians who are routinely part of cancer c...
What is the current status of trial NCT06904391?
This trial is currently recruiting. It is a NA study. The enrollment target is 97 participants. The study started on 2025-09-05. Estimated completion is 2028-06-30.
What conditions does trial NCT06904391 study?
This clinical trial studies the following conditions: Other.
What interventions are being tested in trial NCT06904391?
The interventions under investigation include: Survey Administration (OTHER), Educational Intervention (OTHER), Interview (OTHER), Behavioral Intervention (OTHER).
Who is sponsoring clinical trial NCT06904391?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06904391 being conducted?
This trial has 20 study locations across Delaware, Hawaii, Illinois, Maine, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Other
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06904391's enrollment target sits among peer trials
97 923rd of 2000 higher than 1,076 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03948490 · 97 participants · NA
Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas
- NCT04140487 · 97 participants · Phase 1
Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
- NCT04196413 · 97 participants · Phase 1
GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)
- NCT05223816 · 97 participants · Phase 2
An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI